SIGLEC1 and COVID-19: To address the impact of systemic steroids on the peripheral distribution of CD169-expressing monocytes and DC subsets, a sub-cohort of 20 COVID-19 patients treated with systemic steroids were tested 7 and 14 days from hospital admission.